| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
FutureChem Co Ltd
KOSDAQ:220100
FutureChem Co Ltd
Operating Income
FutureChem Co Ltd
Operating Income Peer Comparison
207940
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Operating Income
-₩8.7B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Operating Income
₩1.1T
|
CAGR 3-Years
55%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Operating Income
-₩15.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Operating Income
₩31.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Operating Income
-₩60.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-24%
|
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
Operating Income
-₩66.9B
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-81%
|
CAGR 10-Years
N/A
|
See Also
What is FutureChem Co Ltd's Operating Income?
Operating Income
-8.7B
KRW
Based on the financial report for Mar 31, 2024, FutureChem Co Ltd's Operating Income amounts to -8.7B KRW.
What is FutureChem Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
7%
Over the last year, the Operating Income growth was 29%. The average annual Operating Income growth rates for FutureChem Co Ltd have been -28% over the past three years , 7% over the past five years .
You don't have any saved screeners yet
